TRIMARCHI, Francesco
 Distribuzione geografica
Continente #
EU - Europa 20.918
NA - Nord America 18.055
AS - Asia 10.711
SA - Sud America 3.824
AF - Africa 308
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 19
Totale 53.856
Nazione #
US - Stati Uniti d'America 17.745
RU - Federazione Russa 10.188
SG - Singapore 4.819
BR - Brasile 3.293
CN - Cina 2.954
IE - Irlanda 2.473
SE - Svezia 2.192
IT - Italia 1.660
HK - Hong Kong 1.094
DE - Germania 1.088
UA - Ucraina 928
FR - Francia 743
VN - Vietnam 599
FI - Finlandia 531
GB - Regno Unito 524
IN - India 296
AR - Argentina 199
BD - Bangladesh 151
CA - Canada 123
MX - Messico 108
TR - Turchia 107
IQ - Iraq 101
EC - Ecuador 91
CO - Colombia 81
NL - Olanda 80
PL - Polonia 78
BE - Belgio 73
ZA - Sudafrica 73
PK - Pakistan 65
AT - Austria 62
UZ - Uzbekistan 60
MA - Marocco 58
JP - Giappone 55
CI - Costa d'Avorio 52
ID - Indonesia 51
ES - Italia 50
CZ - Repubblica Ceca 48
VE - Venezuela 47
TN - Tunisia 36
CH - Svizzera 35
SA - Arabia Saudita 35
AE - Emirati Arabi Uniti 34
IR - Iran 32
CL - Cile 27
UY - Uruguay 27
PY - Paraguay 25
DO - Repubblica Dominicana 22
DZ - Algeria 22
KE - Kenya 22
KZ - Kazakistan 22
AL - Albania 20
AZ - Azerbaigian 19
EG - Egitto 19
JO - Giordania 19
LB - Libano 19
NP - Nepal 18
RO - Romania 18
AU - Australia 17
PE - Perù 17
JM - Giamaica 16
KG - Kirghizistan 16
BO - Bolivia 15
IL - Israele 15
LT - Lituania 15
PH - Filippine 15
MY - Malesia 13
PS - Palestinian Territory 13
PT - Portogallo 12
BG - Bulgaria 11
EU - Europa 11
GR - Grecia 11
HU - Ungheria 10
QA - Qatar 10
CR - Costa Rica 9
BH - Bahrain 8
DK - Danimarca 8
GE - Georgia 8
OM - Oman 8
RS - Serbia 8
TH - Thailandia 8
BY - Bielorussia 7
KR - Corea 7
SN - Senegal 7
SY - Repubblica araba siriana 7
EE - Estonia 6
ET - Etiopia 6
GT - Guatemala 6
HR - Croazia 6
LV - Lettonia 6
MD - Moldavia 6
SK - Slovacchia (Repubblica Slovacca) 6
MN - Mongolia 5
PA - Panama 5
TT - Trinidad e Tobago 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
BN - Brunei Darussalam 4
LU - Lussemburgo 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
Totale 53.794
Città #
Moscow 3.002
Ashburn 2.511
Dublin 2.465
Singapore 2.401
Dallas 1.996
Chandler 1.868
Jacksonville 1.865
Nyköping 1.096
Hong Kong 1.087
Beijing 1.046
San Jose 829
The Dalles 531
Princeton 461
Dearborn 452
Cambridge 435
Los Angeles 430
Lauterbourg 410
Medford 360
Des Moines 346
Ann Arbor 290
New York 290
Munich 243
São Paulo 240
Boardman 223
Buffalo 218
Ho Chi Minh City 188
Messina 181
Lancaster 161
Wilmington 149
Council Bluffs 145
Tianjin 143
Jinan 131
Woodbridge 122
Milan 112
Hanoi 111
Guangzhou 110
Shenyang 107
San Mateo 106
Rio de Janeiro 96
Redondo Beach 89
Nanjing 88
Orem 86
Frankfurt am Main 83
Rome 83
Catania 75
Houston 75
Hyderabad 75
Brussels 72
Santa Clara 72
Turku 68
Seattle 67
Bremen 66
Belo Horizonte 65
Zhengzhou 60
Brasília 59
Tashkent 57
Porto Alegre 53
Pune 53
Abidjan 52
London 51
Warsaw 50
Dong Ket 48
Tokyo 48
San Francisco 46
Shanghai 46
Haikou 44
Hangzhou 44
Hebei 43
Chennai 42
Helsinki 41
Denver 40
Johannesburg 40
Montreal 40
Stockholm 39
Ningbo 38
Shenzhen 38
Taizhou 38
Turin 38
Brooklyn 37
Curitiba 37
Düsseldorf 36
Falls Church 36
Vienna 36
Nanchang 35
Fortaleza 34
Mumbai 34
Baghdad 33
Salvador 33
Guayaquil 31
Ribeirão Preto 30
Atlanta 29
Boston 29
Chicago 29
Toronto 29
Bologna 28
Fuzhou 28
Goiânia 28
Norwalk 28
Brno 27
Haiphong 27
Totale 29.863
Nome #
I LIVELLI SIERICI DI INTERLEUCHINA 23 (IL-23) SONO AUMENTATI NEI PAZIENTI CON TIROIDITE DI HASHIMOTO (TH) DI NUOVA DIAGNOSI RISPETTO AI CONTROLLI SANI 727
IL GRADO DI COINVOLGIMENTO CUTANEO, VALUTATO COME SKIN SCORE SECONDO RODNAN, NEI PAZIENTI CON SCLEROSI SISTEMICA (SS) CORRELA CON I LIVELLI SIERICI DI TSH 323
99mTc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology 275
131I RADIOIODINE THERAPY (RIT) OF HYPERTYROIDISM DUE TO GRAVES’ DISEASE (GD) OR UNI-MULTINODULAR TOXIC GOITER (NTG): OUR EXPERIENCE 257
131I Radioiodine therapy (RIT) of hyperthyroidism due to Graves' disease (GD) or uni-multinodular toxic goiter (NTG): our experience 247
Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy 239
3D representation of human shoulder using volume rendering techniques. 236
Refractoriness of two novel formulations of L-T4 (oral solution and soft gel capsule) to the coffee-induced intestinal absorption of tablet L-T4. 234
Annual increase in the frequency of papillary thyroid carcinoma as diagnosed by fine-needle aspiration at a cytology unit in Sicily. 231
antiphospholipid antibodies syndrome associated with hyperhomocysteinemia related to MTHFR Gene C677T and A1298C heterozygous mutations in a young man with idiopathic hypoparathyroidism (DiGeorge syndrome). 230
Prospective study on the triggering role of stress in Graves' disease. 227
Cardiovascular outcomes and conventional risk factors in nondiabetic adult patients with GH deficiency: a long-term retrospective cohort study 226
3 NEW MUTATIONS OF THYROID-HORMONE RECEPTOR-BETA ASSOCIATED WITH RESISTANCE TO THYROID-HORMONE 222
A case of congenital goiter in an endemic area: histological, immunohistochemical and ultrastructural observations]. 222
Coffee impairs intestinal absoprtion of levo-thyroxine: report of additional cases. 219
Studio prospettico sul ruolo degli eventi stressanti (ES nello scatenamento degli episodi di ipertiroidismo da morbo di Basedow (MB). 215
I livelli sierici di interleuchina 22 (IL-22) sono aumentati nella tiroidite di Hashimoto rispetto alle tireopatie non autoimmuni ed ai controlli sani. 209
Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction. 204
A patient with stress-related onset and exacerbations of Graves disease. 204
Changes in both size and cytological features of thyroid nodule after levothyroxine treatment. 201
DETECTION OF MATERNAL THYROID FAILURE DURING PREGNANCY: SCREENING OR MONITORING? 201
A novel formulation of L-thyroxine (L-T4) solves problems of L-T4 malabsorption caused by coffee in patients under replacement or TSH suppressive L-T4 therapy with conventional tablets. 201
A case of clinically silent acromegaly with erectile dysfunction. 196
Cell proliferation parameters and apoptosis indices in pituitary macroadenomas 194
A liquid formulation of L-thyroxine (L-T4) solves problems of incomplete normalization/suppression of serum TSH caused by proton pump inhibitors (PPI) on conventional tablet formulations of L-T4. 194
Coffee Impairs Intestinal Absorbtion of Levothyroxine: Report of Additional Cases 193
Immunoreactions for P53 isoforms are associated with ultrastructural proliferative profiles in benign thyroid nodules 193
Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: A cohort study 193
A novel formulation of l-thyroxine (l-T4) reduces the problem of l-T4 malabsorption by coffee observed with traditional tablet formulations 192
AN UNUSUAL CASE OF MARINE-LENHART SYNDROME. 192
Association of autonously functioning ("hot") thyroid nodules with Hashimotos' thyroiditis (HT). 190
Association of parathyroid carcinoma and thyroid disorders: A clinical review 190
[Thyro-gastric autoimmunity in a pediatric population of type-I diabetics] 189
Attention deficit and hyperactivity disorders in the offspring of mothers exposed to mild-moderate iodine deficiency: A possible novel iodine deficiency disorder in developed countries 187
Increased annual frequency of Hashimoto's thyroiditis between years 1988 and 2007 at a cytological unit of Sicily. 187
ABLAZIONE RADIOMETABOLICA DEL RESIDUO TIROIDEO POST-CHIRURGICO DOPO STIMOLO CON TSH UMANO RICOMBINANTE (rhTSH) IN PAZIENTI CON OFTALMOPATIA DI GRAVES (OG) DI GRADO MODERATAMENTE SEVERO E SEVERO: STUDIO PROSPETTICO RANDOMIZZATO IN SINGOLO CIECO 187
Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions 186
Un caso di orticaria cronica idiopatica (OCI) associata a morbo di Basedow (MB): tipizzazione HLA. 185
Interference of L-T4 absorption by proton-pump inhibitors (PPIs) can be solved by a liquid ormulation of L-thyroxine (L-T4). 185
Allelic loss at 7q21 is a frequent and early event in thyroid follicular tumors. 184
BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer 183
AUMENTATO STRESS OSSIDATIVO NELLA TIROIDITE DI HASHIMOTO (TH) CON EUTIROIDISMO 182
Effects of maternal iodine nutrition and thyroid status on cognitive development in offspring: A pilot study 182
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 181
Peptide receptor radionuclide therapy with 111IN-DTPA-Octreotide in a woman with Cabergoline-resistant giant prolactinoma 180
Analisi immunoistochimica dei "pathways" del sistema HGF/c-met in noduli tiroidei benigni e maligni. 179
Course of Pregnancy in Cushing Disease under Different Management Approaches (No Treatment, Surgery, Gamma-Knife or Ketoconazole) 179
Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor 178
CD30 and CD30 ligand (CD30L) expression in decidual samples of spontaneous abortions. 178
Attention Deficit and Hyperactivity Disorders due to Iodine Deficiency: A Novel Iodine Deficiency Disorder Affecting the Offspring of Hypothyroxinemic Mothers 177
Acromegalic cardiopathy: a morphofunctional study with color-Doppler echocardiography 177
Deficit di ormone della crescita e sindrome metabolica: effetti del trattamento sostitutivo a lungo termine con GH ricombinante in età adulta. 176
Effectiveness and safety of long-term pegvisomant administration in patients with acromegaly not controlled by other therapies: experience of an Italian center. 176
Analisi immunoistochimica dell'espressione dlel'epidermal growth factor receptor (EGFR) e di HER2 nel carcinoma midollare della tiroide (MCT). 176
A miRNA signature associated with human metastatic medullary thyroid carcinoma. 176
The changing phenotype of iodine deficiency disorders: a review of thirty-five years of research in North-Eastern Sicily 175
A novel point mutation in the ligand-binding domain of the human glucocorticoid receptor (hGR)in a patient with glucocorticoid resistance 174
Increased prevalence of acromegaly in a highly polluted area. 174
I livelli sierici di Interleuchina 37 (IL-37) sono aumentati nella Tiroidite di Hashimoto (TH) e correlano con i marcatori di stress ossidativo 173
A Novel Iodine Deficiency Disorder: Gestational Hypothyroxinemia – How Safe is it for Progeny? 172
Very High Frequency of the Polymorphism for the Insulin Receptor Substrate 1 (IRS-1) at Codon 972 (Glycine972Arginine) in Southern Italian Women with Polycystic Ovary Syndrome. 172
Braf V600E and 99m-TC MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy. 172
Association of primary hyperparathyoidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service. 171
Additional cases of impairment of L-thyroxine (L-T4) intestinal absorption caused by coffee. 171
ACCUMULO DI RADIOIODIO IN MIELOMENINGOCELE SECONDARIO A SPINA BIFIDA OCCULTA: PRIMA EVIDENZA DI CONDIZIONE SIMULANTE UNA METASTASI VERTEBRALE DI CARCINOMA DIFFERENZIATO DELLA TIROIDE 171
Combined BRAFV600Eanalysis and99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation 171
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG) 168
Increased serum interleukin-22 levels in patients with PRL-secreting and non-functioning pituitary macroadenomas. 168
Aplotipi del microsatellite D7S6440, localizzato nell'introne 9 del gene HIPK2, come marcatori molecolari della tiroidite di Hashimoto 168
Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL. 166
Oxidative Stress and Advanced Glycation End Products in Hashimoto's Thyroiditis 165
MRI finding of simultaneous coexistence of growth hormone-secreting pituitary adenoma with intracranial meningioma and carotid artery aneurysms: report of a case 164
Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules 164
Lymphocytic hypophysitis: differential diagnosis and effects of high-dose pulse steroids, followed by azathioprine, on the pituitary mass and endocrine abnormalities--report of a case and literature review. 164
Malattie della Tiroide-Note di anatomia e fisiologia 164
Association of autonomously functioning thyroid nodules (AFTNs) with Hashimoto's thyroiditis (HT) 164
Abnormalities of GH secretion in a young girl with Floating-Harbor syndrome 163
Abla zione radiometabolica dopo rhTSH del residuo tiroideo post -chirurgico in pazienti con orbitopatia di Graves moderatamente severa e severa 163
A congenitally hypothyroid young man (Seated Dwarf, Goya’s Studio, 19th century) 163
Gly972Arg of IRS-1 and Lys121Gln of PC-1 polymorphisms act in opposite way in polycystic ovary syndrome 163
Attention deficit and hyperactivity disorders (ADHD) in the offspring of mothers exposed to iodine deficiency: a possible novel iodine deficiency disorder in developed countries 162
Association between primary hyperprathyroidism (p-hyperPTH) and nodular toxic goiter (NTG): a prospective study at an outpatient service for osteoporosis 162
Myopathy as the persistently isolated symptomatology of primary autoimmune hypothyroidism 162
Abnormal daily periodicity of serum thyrotropin (TSH) and evidencefor defective TSH suppression in a case of non-neoplastic syndrome ofinappropriate TSH secretion. 162
Course of pregnancies in women with Cushing's disease treated by gamma-knife 162
Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly 162
A radioimmunoassay for thyroxine in unextracted serum 160
Thyroid metastases from renal cell carcinoma: review of the literature. 159
CARATTERISTICHE CLINICHE ED ISTOLOGICHE DI UNA SERIE RETROSPETTIVA DI 455 PAZIENTI AFFETTI DA CARCINOMA DIFFERENZIATO DELLA TIROIDE 159
Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes 159
Autoimmune comorbidities in Hashimoto's thyroiditis: different patterns of association in adulthood and childhood/adolescence 159
Predictive markers of recurrence in radically resected pituitary macroadenomas 157
Correlation of cardio-metabolic parameters with vitamin D status in healthy premenopausal women 157
Looking for Increased Prevalence of Hashimoto's Thyroiditis (HT)in Patients with Sarcoidosis (SAR)and Finding an Increased Rate of High Serum Levels of Thyroxine-binding Globulin (TBG)with Presumably Impaired Binding Property. 156
Trattamento di tumori ipofisari mediante Cyber-Knife: Dati preliminari a medio termine su efficacia e sicurezza 156
Iodine-131 treatment of hyperthyroidism: our experience 155
Variations in urinary iodine (UI) during normal pregnancy in different conditions of iodine nutrition. 155
Expressions of Δ 133 isoforms of P53 in multinodular thyroids: the immunoreactions in benign lesions are correlating with subcellular phenotypes of electron microscopy 155
Clinical and histological characteristics of differentiated thyroid cancer (DTC) ina a retrospective series of 406 patients 155
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 155
Totale 19.019
Categoria #
all - tutte 177.422
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 177.422


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021167 0 0 0 0 0 0 0 0 0 0 0 167
2021/20223.051 31 463 58 161 123 36 181 136 77 450 420 915
2022/20237.383 626 578 339 585 570 734 88 436 3.011 46 273 97
2023/20241.937 171 277 161 209 156 430 59 107 4 129 26 208
2024/20259.070 127 128 188 463 428 275 156 2.026 2.231 519 897 1.632
2025/202624.241 1.163 1.717 2.044 1.608 1.954 5.252 3.105 2.920 2.864 911 401 302
Totale 54.290